Navigation Links
First 3D Heads-Up Cataract Surgery Performed in Asia
Date:2/26/2013

Santa Barbara, CA (PRWEB) February 26, 2013

Professor Clement C. Y. Tham, one of the most highly respected and innovative ophthalmological surgeons performed the first 3D “heads-up” cataract surgery in Asia using the TrueVision® 3D Surgical System. The first surgery, performed at the Hong Kong Eye Hospital, took place on December 12, 2012, and used the advanced TrueVision® 3D Visualization and Guidance platform for high-definition, real-time, stereoscopic microsurgery.

“We’re very glad to be the first center and the first hospital in Asia to use the 3D TrueVision® System for heads-up cataract surgery,” said Professor Tham, who is the S.H. Ho Professor of Ophthalmology and Visual Sciences at The Chinese University of Hong Kong, and Honorary Chief of Service of Hong Kong Eye Hospital.

TrueVision® is a stereoscopic high-definition visualization system that displays the surgical field of view in real-time on a 3D flat-panel display in the operating room. It is used for refractive cataract, corneal, glaucoma, and retinal surgeries. The advanced technology is used to visualize, record, and playback microsurgery and to stream live stereoscopic video of the surgical field, making it an unparalleled teaching tool. The Refractive Cataract Toolset® is the first 3D computer-guided application for the correction of astigmatism and advanced IOL placement used to potentially improve surgical efficiencies and patient outcomes.

Prof. Tham, who performed 8 cases over the course of the day, said using the TrueVision® 3D Surgical System provided distinct advantages in visualization and ergonomics in cataract cases.

“I performed cataract surgeries by looking at the TrueVision 3D display without being tethered to the optical eyepiece of the microscope,” said Professor Tham. “One advantage is that I could operate in a much more relaxed posture. This benefit may be even more obvious during m
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013
2. First Bedside DNA Test to be Introduced in Malta by Technoline
3. First Product from Rotman Schools New Creative Destruction Lab
4. University of Chicago Medicine is the First in Illinois to Adopt TrueVision 3D Surgical System for Ophthalmic Surgery and Teaching
5. Ion Semiconductor Sequencing Data Presentations at AGBT Demonstrate More than >1,000-fold Throughput Scaling in First Two Years on the Market
6. Rosemary Gladstar Receives First-Annual ABC Mark Blumenthal Herbal Community Builder Award
7. China Cord Blood Corporation to Report Third Quarter and First Nine Months of Fiscal 2013 Financial Results
8. PeerJ Publishes Its First Articles
9. Venaxis Executes First Commercial Development Agreement and Receives Purchase Order from EMELCA Bioscience for Initial EU Launch
10. Z Trim Holdings, Inc. Records First Non-GMO Corn Sales
11. ARAMARK Introduces Worlds First Reusable Validated Sterile Goggle That Remains Clear When Irradiated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015  For people with Down syndrome, ... day. The biotechnology company, located in the Science + ... the best potential therapies yet for people with Down syndrome ... Correction of Down syndrome and Edwards syndrome aneuploidies in ... DNA Research . Elixirgen plans to develop this technology ...
(Date:8/31/2015)... FRANCISCO, Calif. , Aug. 31, 2015 ... discovery and development of novel cancer immunotherapies, announced today ... Ph.D., as Chief Executive Officer and William Ho ... and Ho join an experienced management team led by ... Jordan Fridman , Ph.D., Chief Scientific Officer; Jay ...
(Date:8/31/2015)... ... August 31, 2015 , ... There’s a new treatment option for ... first commercially available new FDA approved system in the last 14 years, and the ... high Amenorrhea (zero bleeding) rate of 66%, the high Patient Satisfaction rate of 98%, ...
(Date:8/28/2015)... ... August 28, 2015 , ... Proove Biosciences ... the International Spine Intervention Society’ s 23rd Annual Scientific Meeting (ASM). ... 2015. With a focus on evidence-based research and clinical application, the event gathered ...
Breaking Biology Technology:New Down syndrome therapy discovered 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 3FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 4U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 2Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 4
... may seem obvious that dunking relatively spherical objects in ... will result in an array of completely encapsulated berries. ... have similarly dunked their wares in protective coatings in ... chemical interactions with solvents. Unfortunately, reactions in the ...
... Beta-Pro LLC, announced today that it has expanded ... drug discovery and research institutes in the $2 ... now manages extensive laboratory facilities in the University ... "Beta-Pro has already established a foothold ...
... US Oncology, Inc., the nation,s leading integrated oncology ... patient in a Phase I clinical trial through its ... trials present special challenges, including increased safety concerns, higher ... some first-in-human trials, making Phase I trials more difficult ...
Cached Biology Technology:Nanoscopic particles resist full encapsulation, Sandia simulations show 2Beta-Pro Expands Operations to Meet Demands for Human Cells in Hepatocyte Drug Discovery Market 2US Oncology Network Recruits 1,000th Patient to Phase I Oncology Trials 2US Oncology Network Recruits 1,000th Patient to Phase I Oncology Trials 3US Oncology Network Recruits 1,000th Patient to Phase I Oncology Trials 4US Oncology Network Recruits 1,000th Patient to Phase I Oncology Trials 5
(Date:8/11/2015)... Today, ZUK announced its Android smartphone Z1, ... expected revenues in 2015 that relate to sales of FPC1155 for ... approximately 2,200 MSEK for 2015. Jörgen Lantto, CEO of ... smartphone manufacturer in China and ... 155 for Z1 , ...
(Date:8/6/2015)... JOSE, Calif. , Aug. 6, 2015 /PRNewswire/ ... leading developer of human interface solutions, today announced ... TouchPad technologies on Windows 10. Microsoft leveraged Synaptics, ... to the operating system. Through ... drivers are fully certified with Microsoft,s Precision TouchPad ...
(Date:8/4/2015)...  AMRI (NASDAQ: AMRI ) today reported financial and operating ... Highlights: , Second quarter contract revenue of $ ... , Adjusted contract margins of 26 % ... $0.05 decrease in EPS from royalties in the current quarter ... "We are very pleased to present another strong financial quarter, ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2Synaptics Chosen for Human Interface Co-Development on Windows 10 2AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24
... St. Louis, July 31, 2008 Staying awake slows down ... its peak after sleep but inevitably trends downward throughout the ... For the first time, researchers at Washington University School of ... this downward slide. When scientists genetically tweaked a part of ...
... Michigan State University researcher and his students have ... and stronger and could result in more fuel-efficient ... medical and sports equipment. The material ... in the development of new and expanded applications ...
... Auckland, New Zealand - Kiwifruit lovers can look forward ... to the release this week of crucial genetic data ... new varieties with increased health properties and exciting colours ... company HortResearch and listed New Zealand biotech company Genesis ...
Cached Biology News:Brain tweak lets sleep-deprived flies stay sharp 2'Small' research at MSU leads to advances in energy, electronics 2Genetic data promises new future for kiwi fruit 2Genetic data promises new future for kiwi fruit 3
... The BioLogic Maximizer kit, 110 ... and pH monitoring and doubles flow ... DuoFlow chromatography systems. The kit includes ... Maximizer mixer, starter kit, tubing kit, ...
... antifade reagent is used to ... standard fluorescence microscopy. The unique ... a wide variety of fixed ... fluorescein, rhodamine, sulforhodamine 101, coumarin, ...
... FAST RED Chromogen System consists of FAST ... reacts in the presence of alkaline phosphatase ... noise. The FAST RED System provides ... System Contains: , , Vial A: 6 ...
... Dodeca silver stain kits are optimized ... including Bio-Rad Dodeca stainers. This silver ... of proteins in polyacrylamide gels and ... includes sensitizer concentrate, silver reagent concentrate, ...
Biology Products: